XNYS · Healthcare Plans
Last stored close · Nov 10, 2026
Close · Nov 10, 2026
$405.12+1.89%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
50/100
Moderate
Score components
TickerWhale View
Unitedhealth Group scores 50 out of 100 overall, which we rate moderate. Quality & growth is its strongest area and Valuation its weakest.
What helps
- Technical
- Quality & growth
- Sentiment Signal
What to watch
- Valuation
- Risk
Quality & growth
30%78Strong
- Revenue growth 6.4%
- EPS growth -32.5%
Valuation
25%11Weak
- P/E 26.0
- EV/Sales 0.9
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
#28 by market cap in our coverage · ~390,000 employees · Listed 1984-10-17 · www.unitedhealthgroup.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#97 / 139sector rank by TickerWhale Score
TickerWhale Score 50 vs sector average 54.6 (-4.6)
Revenue growth (industry)Top 75%
Gross margin (industry)Top 13%
Return on equity (industry)Top 38%
P/E (industry)Pricier than 67%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
61/100Positive vs universe
Ranks 61st of 100 covered names on our technical composite — the composite itself scores 63/100 · 25% of the TickerWhale Score
Classic chart indicators
Buy
3 buy · 2 sell · 3 neutral of 8 votes
TickerWhale rates UNH's technical setup middling — 61st percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.
Moving averages
7 / 9constructive
- vs 200-day+11.1%
- vs 50-day+3.6%
Momentum
Mixed
- RSI (14)54 · neutral
- Stochasticbuy
- CCIneutral
- Williams %Rneutral
Trend
Mixed
- ADX (14) trend strength25· trending
- MACD (12,26,9)sell(histogram -1.847)
How the classic verdict is reached
Moving averages (9) agree on buy — 7 buy vs 0 sell — and carry one vote between them.
Oscillators (7) vote individually: 2 buy · 2 sell · 3 neutral.
Result — 3 buy vs 2 sell of 8 votes = Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-11-10 · revised_latestValuation multiples
- P/E (TTM)26.0
- P/S (TTM)0.8
- P/B3.7
- EV/EBITDA—
- EV/Sales0.9
- PEG—
Profitability & returns
- Gross margin30.8%
- Net margin3.1%
- ROE14.4%
- Debt/Equity0.74
Growth
- Revenue growth (YoY)6.5%
- EPS growth (YoY)-32.5%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $367.0B
Fundamentals history
Reported statement totals across recent periods.
| Metric | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B |
| Gross profit | $82.9B | $89.4B | $91.0B |
| Operating income | $19.0B | $32.3B | $32.4B |
| Net income | $12.1B | $14.4B | $22.4B |
| EPS (diluted) | $13.23 | $15.51 | $23.86 |
| Free cash flow | $16.1B | $20.7B | $25.7B |
| Cash | $24.4B | $25.3B | $25.4B |
| Total debt | $78.4B | $76.9B | $62.5B |
| Equity | $94.1B | $92.7B | $88.8B |
| Net debt | $54.0B | $51.6B | $37.1B |
| Debt / equity | 0.83 | 0.83 | 0.70 |
| Liabilities / assets | 0.67 | 0.66 | 0.64 |
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: KNSA →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNHCurrentUnitedhealth Group | 50 | 63 | 26.0 | — | 3.7 | 0.9 | $405.12 | +1.89% | +6.5% | ||
| EXELExelixis | 82 | 88 | 21.3 | — | 9.9 | 7.4 | $70.58 | -1.62% | +9.2% | ||
| KNSAKiniksa Pharmaceuticals International plc. - | 79 | 81 | 98.2 | — | 12.1 | 9.3 | $95.02 | -3.79% | +58.9% | ||
| THCTenet Healthcare | 79 | 81 | 10.9 | — | 5.2 | 1.6 | $290.27 | +0.44% | +7.5% | ||
| INCYIncyte | 76 | 67 | 15.5 | — | 3.9 | 3.6 | $120.30 | -1.30% | +26.9% | ||
| LIVNLivaNova | 76 | 84 | 27.2 | — | 3.9 | 3.3 | $91.14 | -1.59% | +12.4% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.